The following startups will present their circular solutions for the life sciences sector.

• Presenter: Göknur Bektas, Founder and Managing Director
• Solution: Recycling and waste management

klaro is a digital waste and resource management solution that gives companies greater transparency over their waste streams, costs and recycling processes. By combining operational waste management with data analysis, invoice verification and optimisation, klaro helps organisations reduce waste, improve recycling and keep valuable materials in circulation.

• Presenter: Olivier Enos, CEO
• Solution: Green chemical processes as alternatives to polluting processes

Deasyl is a Swiss deep-tech company developing innovative, sustainable chemical processes that transform industrial by-products, such as crude glycerol, into high-value bio-based chemicals. Through circular chemistry, Deasyl reduces waste and carbon emissions while providing sustainable alternatives for industries including cosmetics, personal care, and life sciences.

• Presenter: Javier Sánchez, CEO
• Solution: Green consumables for diagnostics

GreenCheck Biotech AG replaces the plastic housings and components of conventional lateral flow rapid tests with a patented, cellulose-based design made from up to 97% renewable materials. This cuts fossil-based plastic in single-use diagnostics and enables shorter, local supply chains. As a drop-in, OEM-ready solution for point-of-care testing across diagnostic fields, it gives the life sciences sector a direct way to reduce plastic waste without changing existing assay workflows.

• Presenter: Dr. Maren Schinz, CEO & Founder
• Solution: Biologics storage and logistics

Beyond Diagnostics is developing LUMIQ, a point-of-use test that verifies whether temperature-sensitive biologic medicines such as insulin are still effective before use. By helping avoid the unnecessary disposal and replacement of medicines whose quality is uncertain, LUMIQ supports more circular use of high-value life science products, reducing pharmaceutical waste, resource consumption, and unnecessary cold-chain losses.

• Presenter: Kami Krista, Co-founder and CEO
• Solution: Carbon footprint of synthetic routes

Elio provides LCA data for pharmaceutical chemicals that are missing from leading LCA databases. Its auditable, deterministic and automated product carbon footprint calculation engine models synthetically made chemicals based on documented synthesis routes from patents and literature. By closing these data gaps, Elio enables pharmaceutical companies to integrate carbon impact into ecodesign and make more informed, lower-carbon choices when designing synthesis routes.

• Presenter: Dr. Philip Zimmermann, CEO
• Solution: Personalised medicine

Prevision Medicine helps oncologists identify the most effective treatments for their individual patients. This avoids unnecessary suffering and high costs associated with ineffective treatment rounds, but also allows identifying new applications for existing drugs through repurposing.